|
EP4793360A2
(en)
|
2006-03-31 |
2026-08-19 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for controlling blood pharmacokinetics of antibodies
|
|
EP3127921A1
(en)
|
2007-09-26 |
2017-02-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method of modifying isoelectric point of antibody via amino acid substition in cdr
|
|
TW201920257A
(zh)
|
2008-04-11 |
2019-06-01 |
日商中外製藥股份有限公司 |
重複結合複數個抗原的抗原結合分子
|
|
TWI654203B
(zh)
|
2010-11-30 |
2019-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
具有鈣依存性的抗原結合能力之抗體
|
|
SG10201609665PA
(en)
|
2011-02-25 |
2017-01-27 |
Chugai Pharmaceutical Co Ltd |
FcɣRIIb-SPECIFIC Fc ANTIBODY
|
|
WO2013002362A1
(ja)
|
2011-06-30 |
2013-01-03 |
中外製薬株式会社 |
ヘテロ二量化ポリペプチド
|
|
JP6322411B2
(ja)
|
2011-09-30 |
2018-05-09 |
中外製薬株式会社 |
複数の生理活性を有する抗原の消失を促進する抗原結合分子
|
|
KR20210074395A
(ko)
|
2011-11-30 |
2021-06-21 |
추가이 세이야쿠 가부시키가이샤 |
면역 복합체를 형성하는 세포내로의 운반체（캐리어）를 포함하는 의약
|
|
CA2865158C
(en)
|
2012-02-24 |
2022-11-01 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule for promoting disappearance of antigen via fc.gamma.riib
|
|
TWI619729B
(zh)
|
2012-04-02 |
2018-04-01 |
再生元醫藥公司 |
抗－ｈｌａ－ｂ*２７抗體及其用途
|
|
CA2879577C
(en)
|
2012-07-27 |
2021-08-03 |
City Of Hope |
An mva vaccine for delivery of a ul128 complex and preventing cmv infection
|
|
TWI855488B
(zh)
|
2012-08-24 |
2024-09-11 |
日商中外製藥股份有限公司 |
FcγRIIb特異性Fc區域變異體
|
|
JP6774164B2
(ja)
|
2012-08-24 |
2020-10-21 |
中外製薬株式会社 |
マウスＦｃγＲＩＩ特異的Ｆｃ抗体
|
|
CN105102618B
(zh)
|
2012-12-27 |
2018-04-17 |
中外制药株式会社 |
异源二聚化多肽
|
|
SG11201508170TA
(en)
|
2013-04-02 |
2015-11-27 |
Chugai Pharmaceutical Co Ltd |
Fc REGION VARIANT
|
|
EA201791366A1
(ru)
*
|
2014-12-19 |
2018-02-28 |
Чугаи Сейяку Кабусики Кайся |
Антитела к c5 и способы их применения
|
|
MX2017005774A
(es)
|
2014-12-19 |
2017-07-28 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
|
|
DK3253407T3
(da)
*
|
2015-02-04 |
2020-06-29 |
Univ Zuerich |
Brug af hla-b27-homodimere til kræftbehandling
|
|
CN114773469B
(zh)
|
2015-02-05 |
2025-12-19 |
中外制药株式会社 |
包含离子浓度依赖性的抗原结合结构域的抗体，fc区变体，il-8-结合抗体及其应用
|
|
CA2977106A1
(en)
*
|
2015-02-27 |
2016-09-01 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof
|
|
US11173179B2
(en)
|
2015-06-25 |
2021-11-16 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
|
|
TWI833684B
(zh)
|
2015-06-25 |
2024-03-01 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體（ｃａｒ）、組合物及其使用方法
|
|
CA2996299C
(en)
|
2015-08-24 |
2022-09-27 |
University Of Cincinnati |
Methods and compositions for the detection of fc receptor binding activity of antibodies
|
|
EP3347045A4
(en)
|
2015-09-10 |
2019-08-28 |
City of Hope |
MVA-GH / GL-PC VACCINATED ANTIBODIES FOR NEUTRALIZING THE INFECTIOSITY OF HUMAN CYTOMEGALOVIRUS AND METHOD THEREFOR
|
|
CN108401431B
(zh)
*
|
2015-12-18 |
2022-01-25 |
中外制药株式会社 |
抗-c5抗体及使用方法
|
|
EA201891420A1
(ru)
*
|
2015-12-18 |
2019-02-28 |
Чугаи Сейяку Кабусики Кайся |
Антитела к миостатину, полипептиды, содержащие варианты fc-областей, и способы их применения
|
|
EP3394098A4
(en)
|
2015-12-25 |
2019-11-13 |
Chugai Seiyaku Kabushiki Kaisha |
ANTI-MYOSTATIN ANTIBODIES AND METHOD OF USE
|
|
CA3016752C
(en)
|
2016-03-08 |
2024-09-17 |
Universitat Zurich |
Hla-b57 open conformers
|
|
CN109562126A
(zh)
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
CN116271014A
(zh)
|
2016-08-05 |
2023-06-23 |
中外制药株式会社 |
用于预防或治疗il-8相关疾病的组合物
|
|
CA3031605A1
(en)
|
2016-08-10 |
2018-02-15 |
Universitat Zurich |
Mhc class ia open conformers
|
|
WO2018139623A1
(en)
|
2017-01-30 |
2018-08-02 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-sclerostin antibodies and methods of use
|
|
CN110520145A
(zh)
*
|
2017-03-31 |
2019-11-29 |
阿尔玛生物医疗公司 |
Hla-b27相关炎性疾病的治疗方法及相关组合物
|
|
CN118853581A
(zh)
|
2017-06-21 |
2024-10-29 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(CARs)、组合物及其使用方法
|
|
EP4640703A3
(en)
|
2017-11-14 |
2026-04-08 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-c1s antibodies and methods of use
|
|
CN108486226B
(zh)
*
|
2018-04-01 |
2022-04-12 |
广东辉锦创兴生物医学科技有限公司 |
Hla-b27等位基因的检测试剂盒及其应用
|
|
MX2021001431A
(es)
|
2018-08-10 |
2021-05-12 |
Chugai Pharmaceutical Co Ltd |
Molecula de union al antigeno anti grupo de diferenciacion 137 (cd137) y su uso.
|
|
JP2022525928A
(ja)
*
|
2019-03-21 |
2022-05-20 |
ガミダ セル リミテッド |
併用療法における移植に適したｎｋ細胞画分の増殖及び増殖ｎｋ細胞画分の使用
|
|
CA3137649A1
(en)
|
2019-05-15 |
2020-11-19 |
Chugai Seiyaku Kabushiki Kaisha |
An antigen-binding molecule, a pharmaceutical composition, and a method
|
|
CN111175490A
(zh)
*
|
2020-01-19 |
2020-05-19 |
泛肽生物科技(浙江)有限公司 |
一种定性检测hla-b27的试剂盒及其检测方法
|
|
CA3189755A1
(en)
|
2020-07-25 |
2022-02-03 |
Regeneron Pharmaceuticals, Inc. |
Modulation of endoplasmic reticulum aminopeptidase 2 (erap2)-mediated immune response
|
|
CN117321084A
(zh)
*
|
2021-04-07 |
2023-12-29 |
雷杰纳荣制药公司 |
用于治疗mhc-1-病变的组合物
|
|
WO2023064850A1
(en)
*
|
2021-10-14 |
2023-04-20 |
Regeneron Pharmaceuticals, Inc. |
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (erap1) inhibitors
|
|
WO2023220263A1
(en)
*
|
2022-05-13 |
2023-11-16 |
Memorial Sloan-Kettering Cancer Center |
Compositions and methods for modulating tcr
|